Regulations.gov document
Request for Reconsideration and Revision from Eli Lilly and Company (Hogan Lovells US LLP)
Other · FDA-2017-E-5106 · posted Feb 1, 2019
Key facts
| Document ID | FDA-2017-E-5106-0007 |
|---|---|
| Title | Request for Reconsideration and Revision from Eli Lilly and Company (Hogan Lovells US LLP) |
| Document type | Other |
| Subtype | Request for Reconsideration |
| Agency | FDA |
| Docket | FDA-2017-E-5106 |
| Posted | Feb 1, 2019 |
| Comment period opens | Feb 1, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: